Tokyo, Japan

Yugo Ikeda


Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 57(Granted Patents)


Location History:

  • Hoya, JA (1976)
  • Sayama, JP (1983)
  • Tokyo, JP (1979 - 1994)

Company Filing History:


Years Active: 1976-1994

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Yugo Ikeda: Innovator in Pharmaceutical Treatments

Introduction

Yugo Ikeda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cerebrovascular disorders and dementia. With a total of 5 patents to his name, Ikeda's work has the potential to impact many lives.

Latest Patents

Ikeda's latest patents include a method for the treatment of dementia and cerebrovascular disorders. This method involves administering a therapeutically effective amount of a compound known as 1-[3-(dimethylamino)propyl]-1-phenylphthalane. The compound is designed to inhibit platelet aggregation in patients in need. Another notable patent involves pyrazoloindazole derivatives, which have bronchodilating action and are useful as a medicine. These compounds are characterized by their unique chemical formulas and potential therapeutic applications.

Career Highlights

Throughout his career, Yugo Ikeda has worked with several notable companies, including Chugai Seiyaku Kabushiki Kaisha and H. Lundbeck A/S. His experience in these organizations has allowed him to develop innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key figure in his field.

Collaborations

Ikeda has collaborated with esteemed colleagues such as Minoru Shindo and Yasuo Fujimura. These partnerships have fostered an environment of innovation and have contributed to the advancement of pharmaceutical treatments.

Conclusion

Yugo Ikeda's contributions to the field of pharmaceuticals are noteworthy. His innovative patents and collaborations highlight his commitment to improving medical treatments. His work continues to inspire future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…